References
- Sreedhar A, Li J, Zhao Y. Next-gen therapeutics for skin cancer: nutraceuticals. Nutr Cancer. 2018;70(5):697–709.
- Vishwakarma V, New J, Kumar D, et al. Potent antitumor effects of a combination of three nutraceutical compounds. Sci Rep. 2018;8(1):12163.
- Booth L, Roberts J, West C, et al. GZ17-6.02 initiates DNA damage causing autophagosome-dependent HDAC degradation resulting in enhanced anti-PD1 checkpoint inhibitory antibody efficacy. J Cell Physiol. 2020. DOI:https://doi.org/10.1002/jcp.29464
- Ghosh C, Paul S, Dandawate P, et al. Super-enhancers: novel targets for pancreatic ductal adenocarcinoma. Oncotarget. 2019;10(16):1554–1571.
- Sample A, He Y. Autophagy in UV damage response. Photochem Photobiol. 2017;93(4):943–955.
- Siegel JA, Korgavkar K, Weinstock MA. Current perspectives on actinic keratosis: a review. Br J Dermatol. 2017;177(2):350–358.
- Janse MHE, Kessels J, Nelemans PJ, et al. Randomized trial of four treatment approaches for actinic keratosis. N Engl J Med. 2019;380(10):935–946.
- Cunningham TJ, Tabacchi M, Eliane JP, et al. Randomized trial of calcipotriol combined with 5-fluorouracil for skin cancer precursor immunotherapy. J Clin Invest. 2016;127(1):106–116.